RECRUITING

Post Pandemic Pneumococcal Carriage Among Children and Adults

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The PI propose to conduct a genomic epidemiology study of pneumococcal carriage among children and adults in a large metropolitan city. These data will allow PI to assess the post-pandemic population structure, investigate the phylogenetic relationship between isolates from children and adults, and compare pneumococcal populations across diverse geographic areas.

Official Title

Post-Pandemic Genomic Epidemiology of Pneumococcal Carriage Among Children and Adults in the General US Population

Quick Facts

Study Start:2024-06-12
Study Completion:2026-03
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06373328

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:7 Months
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Children, ages 7 to 59 months (less than 5 years)
  2. * Adults, ages 50 and older
  3. * Ability to provide informed consent (from parents for children participants)
  4. * ability to read and speak in English
  5. * Agree to comply with study procedures (complete online data questionnaire and provide a nasopharyngeal collection).
  1. * Have been on an antibiotic in the last 2 weeks
  2. * Have a respiratory infection that would make an nasopharyngeal collection improbable
  3. * Have underlying developmental or chronic conditions impacting immune or respiratory function (e.g., immunocompromised, cystic fibrosis, cerebral palsy, paralysis)
  4. * Adults unable to consent, individuals who are not yet adults, and prisoners will be excluded from this study.

Contacts and Locations

Study Contact

Amoy Fraser, PhD, CCRP, PMP
CONTACT
4072668742
amoy.fraser@ucf.edu
Erica Martin, B.S.
CONTACT
4072668742
erica.martin@ucf.edu

Principal Investigator

Taj Azarian, PhD
PRINCIPAL_INVESTIGATOR
University of Central Florida

Study Locations (Sites)

University of Central Florida
Orlando, Florida, 32827
United States

Collaborators and Investigators

Sponsor: University of Central Florida

  • Taj Azarian, PhD, PRINCIPAL_INVESTIGATOR, University of Central Florida

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-06-12
Study Completion Date2026-03

Study Record Updates

Study Start Date2024-06-12
Study Completion Date2026-03

Terms related to this study

Keywords Provided by Researchers

  • Nasopharyngeal
  • Children
  • Pandemic
  • Genomic
  • Epidemiology
  • Pneumococcal Carriage
  • Streptococcus pneumoniae

Additional Relevant MeSH Terms

  • Pneumococcal Carriage